<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2021</study_start_year><data_sharing_plan>IPD Sharing (as of July 2022): No
Description: The data involves the relevant personal privacy information of the patient</data_sharing_plan><condition>Colorectal Cancer Stage IV</condition><condition>Lymph Node Yield</condition><condition>Colorectal Neoplasms</condition><disease>Colorectal Cancer Stage Iv</disease><disease>Lymph Node Yield</disease><disease>Colorectal Neoplasms</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2749152</full_dataset_link><location>China</location><study_start_month>5</study_start_month><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Prognostic Impact of Increased Lymph Node Yield in Colorectal Cancer Patients With Synchronous Distant Metastasis: a Population-based Study of the US Database and a Chinese Registry</name><description>The National Quality Forum has endorsed at least 12 lymph node yield (LNY) as a surgical quality indicator in colorectal cancer (CRC), but the prognostic value of adequate lymphadenectomy has rarely been investigated for CRC patients with distant metastatic disease.</description><dates><creation>2021-05-15</creation></dates><accession>2749152</accession><cross_references><ClinicalTrials___gov>NCT05550701</ClinicalTrials___gov></cross_references></HashMap>